Lawsuit Overview
Oct. 15, 2012 (Shareholders Foundation) -- An investor in NASDAQ:CRDN shares filed a lawsuit in effort to stop the proposed buyout of Ceradyne, for $35.00 per NASDAQ:CRDN share. The plaintiff alleges that directors of Ceradyne, Inc. breached their fiduciary duties owed to NASDAQ:CRDN investors arising out of the attempt to sell the company too cheaply via an unfair process to 3M. O...
You must register (for free) or login to view the entire case.